Authored By: Sarah
11 Feb 2025

Travel Vaccines Market 2024-2028, Poised for Strong Growth Amid Rising Global Travel

The Global Travel Vaccines Market is set for significant expansion, with its size projected to increase by USD 3.97 billion between 2024 and 2028, registering a CAGR of 8.64%. The growing trend of international travel, medical tourism, and increased awareness of vaccine-preventable diseases are fueling market growth. However, challenges such as the lack of insurance coverage for travel vaccines may pose constraints.

For more details about the industry, get the PDF sample report for free

Market Segmentation

The market research report provides insights into key market segments based on disease type, end-user, and geography.

By Disease Type

Influenza
Diphtheria
Hepatitis
Typhoid and Others

The influenza segment is expected to witness substantial growth due to rising infection rates. According to the Centers for Disease Control and Prevention (CDC), influenza virus infections in the US led to:

8.1 - 13.9 million illnesses
3.7 - 6.1 million doctor visits
81,000 - 171,000 hospitalizations
5,000 - 14,000 deaths (from October 2021 to June 2022)

By End-User

Adult Vaccines
Pediatric Vaccines

By Geography

North America
- US
Europe
- Germany
- UK
Asia
- China
- Japan
Rest of the World (ROW)

Market Drivers

Increase in Global Migration

The growing frequency of international travel and immigration has accelerated the spread of various infectious diseases. Examples include:

H5N1 avian flu, initially detected in China, which later affected humans
Tuberculosis, a major health concern in developing countries, but also detected in Europe due to migration

Governments and travel clinics have intensified vaccination awareness initiatives, further propelling market demand.

Market Trends

Changes in the Demographic Profile of Travelers

Migrants to countries like the US, Canada, Germany, Australia, and Singapore may have lower vaccination rates, increasing susceptibility to diseases.
Younger travelers (under 30) are more likely to receive travel vaccinations based on medical advice.

Market Challenges

Lack of Coverage for Travel Vaccines in Health Plans

Travel vaccines are often not covered by insurance, forcing individuals to pay high out-of-pocket costs.
A US travel clinic consultation may cost USD 100, with vaccine administration fees ranging from USD 50 to USD 1,000 or more.
Vaccines for rabies, typhoid, measles, and mumps can be expensive, making affordability a key challenge.

Get more details by ordering the complete report